本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
BEIJING, Feb. 24, 2023 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo") today announced that its subsidiary, Yangpu Fangyuyuan United Logistics Co. ("Yangpu Fangyuyuan"), has entered into a joint venture agreement (the "Agreement") with Hainan Yonghuiju Technology Co. ("Hainan Yonghuiju"), an agricultural products logistics company in China, to jointly develop internet of things and logistics business. Pursuant to the Agreement, Yangpu Fangyuyuan and Hainan Yonghuiju will collaborate on the digitalization of online logistics platform and supply chain system to support the sales and delivery of Hainan Yonghuiju's fresh fruit products as the first project. The parties will also work together on the upgrade and advancement of the platform to optimize its operation and efficiency. Backed by ReTo, Yangpu Fangyuyuan will provide platform management and supply chain financing and digitalization services. Hainan Yonghuiju will utilize industry experience and resources in the logistics sector. Yangpu Fangyuyuan and Hainan Yonghuiju are committed to building a platform that empowers logistics company clients with new technologies and business models to offer better services for their customers of various sizes. The joint venture will serve as a hub that coordinates different resources and relationships to construct a scalable and efficient delivery service network for logistics companies. Mr. Hengfang Li, Chairman and CEO of ReTo, commented: "The commitment from Hainan Yonghuiju is another example of how we are playing an essential role in helping our clients achieve the goal of digitalization in the logistics and transportation sector. We hope to expand our presence in the dynamic and growing logistics industry, better positioning ourselves to take advantage of new opportunities. At ReTo, we'll grow our logistics service network in China to meet customers' demands, as well as building our intermodal shipping capacity." About Hainan Yonghuiju Technology Co. Hainan Yonghuiju Technology Co. is responsible for the operation of "Sanya Municipal Government Agricultural Products Distribution Office" in Zhengzhou and has a stable sales network of agricultural products in East China, North China and Southwest China. It has been expanding into new areas and markets based on local resources and advantages with strong support from the municipal government and the bureau of agricultural reclamation. At present, Hainan Yonghuiju provide agricultural products LTL transportation services covering Beijing, Zhengzhou, Jinan, Shanghai, Jiaxing, Hangzhou, Chongqing, Chengdu, Guangzhou and other large and medium-sized cities where it has a sales office in each city. About ReTo Eco-Solutions, Inc. Founded in 1999, ReTo, through its proprietary technologies, systems and solutions, is striving to bring clean water and fertile soil to communities worldwide. ReTo, through its operating subsidiaries in China, is engaged in the manufacture and distribution of eco-friendly construction materials (aggregates, bricks, pavers and tiles), made from mining waste (iron tailings), as well as equipment used for the production of these eco-friendly construction materials. In addition, ReTo provides consultation, design, project implementation and construction of urban ecological protection projects and parts, engineering support, consulting, technical advice and service, and other project-related solutions for its manufacturing equipment and environmental protection projects. ReTo also offers roadside assistance services and software development services utilizing Internet of Things technologies. For more information, please visit: http://en.retoeco.com. Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When ReTo uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: ReTo's goals and strategies, including those related to ReTo's future business development such as supply chain service offering; product and service demand and acceptance; changes in technology; economic conditions; the growth of the industries in China in which ReTo operates; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and assumptions underlying or related to any of the foregoing and other uncertainties and risks contained in reports filed by ReTo with the Securities and Exchange Commission (the "SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in ReTo's filings with the SEC, which are available for review at www.sec.gov. ReTo undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. For more information, please contact: ReTo Eco-Solutions, Inc.Angela HuBeijing Phone: +86-010-64827328ir@retoeco.com or 310@reit.cc
TOKYO, Feb. 7, 2023 /PRNewswire/ -- NEXT MEATS Co., Ltd. a Japanese subsidiary of NEXT MEATS Holdings, Inc. (OTC Market in the U.S.A. listed corporation as "NXHM") Tokyo based food-tech venture company which is the inventor of the newest Non-GMO soybean protein based alternative meats product named "Next Short Rib 2.0" participates with Van Gelder (Founded in Netherlands in 1953) Ridderkerk, Netherlands based the most prominent fresh vegetables and fruits producer/wholesaler to participate HORECAVA which has been hosting the largest food and hospitality convention in Amsterdam since 1957. At HORECAVA 2023, Van Gelder was given the premier opportunity to exhibit and offer tasting of the latest product from Japan. Without any additives and preservatives, "Next Short Rib 2.0" has up to 1 year of shelf life at room temperature, thanks to its proprietary vacuum packing "RETORT" technology developed by its group company MAMA FOODS Co., Ltd. (Founded in 1958) in Hanamaki, Japan. NEXT MEATS Co., Ltd. hopes this innovation allows cost reduction to international importers, wholesalers, retailers and all the way to the final consumers, as well as reducing potential food waste inclusively. Based on the mutually signed MOU, NEXT MEATS Co., Ltd. is planning for the exclusive wholesale package of unflavored "Next Short Rib 2.0" for Van Gelder to start distributing to its existing customers in Netherlands in the 1st quarter of 2023, and to create co-branded ready-to-cook food packages in Netherlands and surrounding countries starting from mid 2023. Both companies received many "LEKKER!" (Delicious in Dutch) comments from the attendees of HORECAVA 2023. Left and right pictures taken with Mr. Leo Rodenrijs (Manager New Business Development of Van Gelder) Center picture taken with Mr. Gerrit van Gelder (CEO of Van Gelder) and Mitsuru Anthony Ueno (COO of Next Meats USA) Van Gelder is a very modern fruit and vegetable supplier and family business. They have been delivering fresh potatoes, vegetables and fruit daily for more than 65 years. To achieve this, Van Gelder controls all of the supply chain, from source to serving. Van Gelder connects growers to customers and has the highest turnover rate in the market. In 2022 they created a new plant based assortment, which they will continue expanding. www.vangeldernederland.nlhttps://twitter.com/VanGelderNLhttps://www.facebook.com/VanGelderNederlandhttps://www.youtube.com/user/VanGelderNL NEXT MEATS Co., Ltd. a Japanese subsidiary of NEXT MEATS Holdings, Inc. (OTC Market in the U.S.A. listed corporation as "NXHM") is Tokyo based food-tech venture company that has been devoted for the research, development and in-house production of premium Japanese-style alternative meat products made with non-GMO soy bean protein since 2020. Our range of products started from the world's first plant-based Yakiniku Short-Rib and Skirt-Steak to Beef Bowl, Chicken, Burger Patties, Pork, Tuna and Milk for both professional and family use. We continue to develop new products and grow business both in Japan and around the world, focusing on Southeast Asia in order to pass down a sustainable global environment to the next generation. We venture into the global market with a proposal of "NEXT Food" choices from Japan. For further information, please contact the following. https://www.nextmeats.global/ https://www.facebook.com/NextMeats/https://www.facebook.com/nextmeats.singapore/https://www.instagram.com/nextmeatsjapan/https://www.instagram.com/nextmeats_singapore/
The cutting-edge genomics technology behind this strawberry variety presents an opportunity to transform the US$ 12 trillion agriculture[1] industry SINGAPORE, Feb. 2, 2023 /PRNewswire/ -- Singrow, a Singapore-based agri-genomics firm that has developed a proprietary genomics technology platform, has just announced the launch of the world's first climate-resilient strawberry variety. The novel strawberry variety is the first application of this transformative technology. The company is currently developing other crop segments that will address food security challenges around the world, especially in Asia and Africa, that were impacted by climate change. The success of the novel strawberry variety and other innovations can be a gamechanger in this global fight against food insecurity and malnutrition. These new growing methods that are based on advanced genomics science will help create nutrient-dense crop varieties that are resilient to drought and disease. Seasonal strawberries traditionally grown in temperate climate are exported across the world to Southeast Asia, leading to the fruit being expensive in the region. More importantly, the exports leave a huge carbon footprint. With its climate-resilient and high-yield producing qualities, Singrow Strawberries can now be grown at scale in tropical countries, breaking seasonal and temperature barriers and unlocking huge potential for growers while also reducing costs for consumers. "Singrow is the first company to successfully utilise genomics technology to develop a sustainable commercial strawberry variety that can grow in tropical climate such as Singapore and Southeast Asia. The success of this strawberry variety is the culmination of several years of research and we are excited to share this announcement with the global agricultural community," said Dr. Bao Shengjie, CEO and Chief Scientist at Singrow. Singrow uses advanced genomics technology that leverages deep understanding of plant genomes to improve crop nutrition and yield with varieties that are also disease and climate resilient. These methods are more productive than conventional breeding. Numerous benefits of this technology have led to increasing adoption across the globe as can be seen in China's recent approval of gene-edited crops[2], and the planting of nutrient-enriched "Golden Rice" in the Philippines[3]. The scalable technology presents a significant opportunity for the agriculture industry as it can be applied to many staple crops that are facing challenges brought about by climate change. Singrow has started work on producing new crop varieties via the same technology and is working on expanding the list of produce to other crop segments such as rice, corn, sustainable palm oil and other staple vegetables that form a huge part of everyday diet. Dr. Bao concludes, "Warmer temperatures caused by climate change has had significant impact on food production. We believe that molecular and genomics crop-breeding technologies is the future for agriculture and we are proud to invent the future of agriculture in Singapore and tackle the toughest problems to secure the future of food." About Singrow Singrow is a Singapore-based agri-genomics firm which developed its proprietary genomics technology platform to address the critical needs of agriculture. Through genome sequencing, annotation and gene adaption and application, the firm has successfully developed the world's first climate-resilient strawberries. Singrow's genome technology is set to transform the US$12 trillion agriculture industry, as it scales and apply the same innovative technology to other crop varieties that forms a huge part of our everyday consumption. For more information, please visit http://www.singrow.net. [1] ResearchandMarkets.com's Agriculture Global Market Report: https://www.researchandmarkets.com/reports/5600249/agriculture-global-market-report-2022?utm_source=CI&utm_medium=PressRelease&utm_code=k3nxj8&utm_campaign=1729397+-+Agriculture+Global+Market+Report+2022&utm_exec=jamu273prd [2] https://www.nature.com/articles/d41586-022-00395-x#:~:text=Researchers%20in%20China%20are%20excited,adapted%20to%20a%20warming%20world. [3] https://www.irri.org/news-and-events/news/philippines-becomes-first-country-approve-nutrient-enriched-golden-rice
Pope Supports Continued Efforts Against Leprosy, Reflects on Tragedy of War TOKYO, Jan. 27, 2023 /PRNewswire/ -- WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa had an audience with His Holiness Pope Francis at the Vatican on January 26, 2023, during which he requested the Pope's support in eliminating leprosy and the prejudice and discrimination associated with the disease. His Holiness Pope Francis and Mr. Yohei Sasakawa, WHO Goodwill Ambassador for Leprosy Elimination(Photo by Vatican Media via Vatican Pool/Getty Images) In response, the Pope expressed his gratitude for the work of the Goodwill Ambassador, who also serves as Chairman of The Nippon Foundation, and said it was necessary to continue activities against leprosy, also known as Hansen's disease, encouraged by the fact it is curable. Earlier in the week, Sasakawa attended a two-day international symposium on Hansen's disease titled "Leave No One Behind." It was the second symposium on Hansen's disease to be held at the Vatican since 2016 and was co-hosted by French Raoul Follereau Fondation, Italian Association Amici di Raoul Follereau and Sasakawa Leprosy (Hansen's Disease) Initiative, in collaboration with the Dicastery for Promoting Integral Human Development. Pope Francis sent a message to participants on the opening day, thanking them for their commitment and saying, "We must not ignore this disease, which unfortunately still afflicts many people, especially in the most disadvantaged social contexts." He added that the upcoming 70th World Leprosy Day, celebrated on Jan. 29, was "a fitting occasion to try to renew our commitment to building an inclusive society, that leaves no-one at the margins." During the private audience, Pope Francis, who visited the Japanese city of Nagasaki in 2019, produced a photograph taken after the atomic bombing of the city in August 1945. It shows a young boy waiting in line at a crematorium, carrying his dead sibling on his back. "War is a tragedy," Pope Francis said. "War must never happen again." At the end of their meeting, the Goodwill Ambassador asked the Pope to pose for a photograph next to a banner reading "Don't Forget Hansen's Disease", a campaign that Sasakawa initiated in 2021 to ensure that leprosy is not overlooked even amid the coronavirus pandemic. "This one photograph will help persons affected by leprosy all over the world," he told the Pope. Speaking afterward, Sasakawa commented: "It is clear how much warmth and love Pope Francis has for the oppressed. He has given me great strength and filled me with courage in my work against leprosy and the stigma and discrimination it causes." The photo that Pope Francis showed the Goodwill Ambassador: In the run-up to New Year 2018, the Pope had cards of the photo printed, instructing that "The fruit of war" be written on the back above his signature, together with details of the image, including the description: "The young boy's sadness is expressed only in his gesture of biting his lips which are oozing blood." The photo was taken by U.S. Marine photographer Joe O'Donnell in Nagasaki in 1945. About Leprosy Leprosy, also known as Hansen's disease, is an infectious disease that mainly affects the skin and peripheral nerves. Prior to the COVID-19 pandemic, which disrupted case-finding activities, over 200,000 new cases were being reported annually. Leprosy is curable with multidrug therapy, but left untreated can result in permanent disability. An estimated 3 to 4 million people are thought to be living with some form of disability as a result of leprosy. Many myths and misunderstandings surround the disease. In various parts of the world, patients, those who have been treated and cured, and even their family members continue to be stigmatized. The discrimination they face limits their opportunities for education, employment and full participation in society. About Sasakawa Leprosy (Hansen's Disease) Initiative The Initiative (https://sasakawaleprosyinitiative.org/) is a strategic alliance between WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa (https://www.nippon-foundation.or.jp/en/who/message/profile), The Nippon Foundation (https://www.nippon-foundation.or.jp/en) and Sasakawa Health Foundation (https://www.shf.or.jp/en) for achieving a world without leprosy and problems related to the disease. Since 1975, The Nippon Foundation and Sasakawa Health Foundation have supported the national leprosy programs of endemic countries through the WHO, with support totaling some US$200 million to date. In cooperation with the Japanese government and other partners, the foundations have played an important role in advocating with the United Nations, helping to secure a 2010 UN General Assembly resolution on elimination of discrimination against persons affected by leprosy and their family members and the appointment of a UN Special Rapporteur on leprosy by the UN Human Rights Council in 2017.
HONG KONG, Jan. 27, 2023 /PRNewswire/ -- Winners of the 36th International ARC Awards have been announcement. The 2021 annual report of Fosun International Limited ("Fosun International" or the "Company", HKEX: 00656) won Gold Award in the "Traditional Annual Report" category of the 2022 International ARC Awards. The award commends Fosun International's annual report for its distinctive theme, clear business and development strategies, sufficient content and forward-looking perspective, and excellent concept and layout design. Hailed as the "Academy Awards of annual reports", the International ARC Awards is the world's most prestigious competition honoring excellence in annual reports. Some of the elements to be considered in the judging of the annual reports include theme of the annual report, chairman's letter, the company's business development and strategy, cover and interior design, presentation of corporate information, expression of financial data, and how well the spirit of the organization is communicated. Judges come from around the globe to participate on the ARC jury panels. Preliminary judging is carried out by panels of judges representing leaders in the fields of investments, writing, design and photography. Final judging is made by presidents, CEOs and other senior executives of corporations, agencies, and design firms. Winners are granted Honors, Bronze, Silver, and Gold awards. In addition to Fosun International, CK Hutchison Holdings and NWS Holdings also won awards in the Traditional Annual Report - Diversified Business category of the 2022 International ARC Awards. Winners of the International ARC Awards this year include many well-known large Chinese and foreign companies, including CLP Holdings, Airport Authority Hong Kong, Hang Seng Bank, Industrial and Commercial Bank of China, China Construction Bank, New World Development, China Telecom, China Mobile, Alibaba, etc. The awards demonstrates the market's recognition of Fosun's business strategy The theme of Fosun International's 2021 annual report was "Sustain Resilience and Accumulate Capabilities to Empower the Future". In 2022, despite the volatile global epidemic situation and the headwinds of anti-globalization, Fosun is still a firm practitioner of globalization. In 2022, COMIRNATY® COVID-19 mRNA vaccine continued to provide an anti-epidemic barrier for Hong Kong SAR, Macao SAR and the Taiwan region; Club Med opened new resorts; Lanvin Group was successfully listed on the New York Stock Exchange. In the face of uncertainties, Fosun remained committed to technology and innovation in order to weather market cycles. HANQUYOU, independently developed by Henlius, was successfully launched in Australia after entering the European Union market; the registration application in the Chinese Mainland for the new indication of Yi Kai Da, China's first CAR-T cell therapy was officially accepted. In recent years, although the global market has been going through different stages of the economic cycle, Fosun has remained committed to its core businesses. Looking forward to 2023, Fosun has mapped out the future direction for development: Fosun will reinforce its positioning as "a global innovation-driven consumer group", focus on its core businesses strategically around the consumption needs of global families, and strengthen the two core growth engines of globalization and innovation. Since the beginning of the year, Fosun's main businesses centering on household consumption, such as Health, Happiness, and Wealth, have shown signs of strong recovery and its forward-looking efforts in the anti-epidemic field have gradually borne fruit. The two flagships of Fosun's Happiness segment, Fosun Tourism Group and Yuyuan have shown strong signs of recovery. According to market sources, when the domestic tourism industry suffered a huge setback in 2022, Fosun Tourism Group still stood firm to build global presence and opened seven new Club Med resorts throughout the year. Club Med's global bookings in the first half of 2023 have greatly exceeded the same period in 2019 before the pandemic. During the 2023 New Year holiday period, Atlantis Sanya, FOLIDAY Town Lijiang and other businesses in China all performed better than their respective pre-pandemic levels, and many Club Med resorts in China recorded close to 100% occupancy. During the 2023 New Year holiday period, the 2023 Yuyuan Garden Lantern Festival in the Grand Yuyuan attracted a large number of tourists. It is expected that the Spring Festival will further unleash consumption vitality. Fosun's anti-epidemic "vaccine and drug" products have attracted great attention from the market. The self-paid vaccination service of COMIRNATY® bivalent vaccine was launched in Hong Kong SAR and vaccination is open to people including Mainland Chinese residents starting from 6 January 2023. After the self-paid vaccination service of COMIRNATY® monovalent COVID-19 mRNA vaccine has opened for non-local residents in Macau SAR last year, it is informed that the COMIRNATY® bivalent vaccine became a regular imported vaccine in Macao SAR on 20 January 2023, and people in need may receive a booster dose with prescription. As regards Azvudine tablets, the oral medication for COVID-19, it is now included in the medical insurance scheme in 31 provinces, autonomous regions, and direct-administered municipalities across the country. It is rapidly expanding its coverage in hospitals and is now available in major healthcare institutions across the country, including secondary hospitals, tertiary hospitals, and primary healthcare institutions. The accessibility of Azvudine tablets has been greatly enhanced, helping the vast areas build a barrier against severe cases. The market is optimistic about Fosun's strategies of accelerating its strategic transformation and focusing on household consumption sectors. A number of investment banks, including Morgan Stanley, Citi, Goldman Sachs and Nomura have published reports and assigned Fosun International an "Overweight" or "Buy" rating. International ARC Awards Established in 1987, the International ARC Awards is the world's renowned competition honoring excellence in annual reports. Hailed as the "Academy Awards of annual reports", the International ARC Awards is globally recognized for its openness and fairness, providing a platform for the highest standards in the annual report industry. Every year, it attracts more than a thousand companies from different industries, government agencies, non-profit organizations as well as other organizations around the world to enter the competition.
HONG KONG, Jan. 26, 2023 /PRNewswire/ -- Fosun International Limited ("Fosun International" or the "Company") (HKEX: 00656) was informed by The Asset, the renowned international asset management and investment magazine, that Fosun has garnered the Platinum Award at The Asset ESG Corporate Awards 2022. This year, Fosun International was accredited with the Platinum Award by The Asset for the first time after being presented with the Gold Award for four consecutive years. The Asset also awarded Fosun International Best Investor Relations Team Award. Organized by The Asset, a renowned Asian financial magazine, The Asset Corporate Awards that has been running for many years is one of the world's leading environmental, social and governance (ESG) awards. This year, Fosun International was accredited with the Platinum Award at The Asset ESG Corporate Awards 2022, reflecting the magazine's recognition of Fosun's outstanding performance in various fields including financial performance, management, corporate governance, social and environmental responsibility, investor relations, information disclosure and corporate communication. Other recipients of the Platinum Award include Agricultural Bank of China, Bank of China (Hong Kong), China Overseas Land and Investment, China Unicom, Kerry Properties, Shui On Land, Sino Land, etc. Fosun International's ESG performance has been highly recognized by rating agencies In recent years, global investors and stakeholders have attached increasing importance to the ESG performance of enterprises. Fosun International has been continuing to promote the development of ESG and has achieved impressive results. Its MSCI ESG rating was AA and the Hang Seng Sustainability rating was A. Fosun International has been selected as a constituent stock of Hang Seng ESG 50 Index (top 50 large-to-mid cap) for two consecutive years and it has been included as a constituent stock of the Hang Seng Corporate Sustainability Benchmark Index for three consecutive years, which includes 87 Hong Kong-listed companies with the most outstanding performance in corporate sustainability (top 20% of the Hang Seng Composite Index constituent stocks). All these affirm Fosun's ESG achievements and the global recognition of Fosun's ESG efforts. Fosun's two treasures, "drug + vaccine" highlight the Group's innovative achievements and social responsibility contributions to the fight against the pandemic The technology innovation capabilities that Fosun accumulated over the years have continued to bear fruit. On 19 December 2022, COMIRNATY®, including the monovalent COVID-19 mRNA vaccine (BNT162b2) and the bivalent vaccine which can protect against the Omicron variant, was officially registered as a drug/product (biological product) in Hong Kong SAR. The self-paid vaccination service of COMIRNATY® bivalent vaccine was launched in Hong Kong SAR and vaccination is open to people including Mainland Chinese residents starting from 6 January 2023. After the self-paid vaccination service of COMIRNATY® monovalent COVID-19 mRNA vaccine has opened for non-local residents in Macau SAR last year, the COMIRNATY® bivalent vaccine was approved by Macao SAR as a regular imported vaccine on 20 January 2023, and people in need may receive a booster dose with prescription. As regards Azvudine, the oral medication for COVID-19, it is now included in the medical insurance scheme in 31 provinces, autonomous regions, and direct-administered municipalities across the country. In addition to tertiary hospitals and secondary hospitals, Azvudine has gradually covered grassroots medical institutions in many provinces. The accessibility of Azvudine has been greatly enhanced, helping the vast areas build a barrier against severe cases. Improving communication in the global capital market, Fosun's long-term strategy has been recognized by investors In recent years, the global market has been going through different stages of the economic cycle. Fosun has focused on its core businesses, deepened innovation and globalization, and maintained long-term effective communication with the capital market and investors. In 2022, Fosun overcame challenges such as the pandemic, and completed 420 domestic and overseas investor roadshows in 11 countries and regions around the world to actively communicate with global investors. Fosun has received high recognition and support from investors for its long-term strategy and corporate value. The Asset awarded Fosun International the "Best Investor Relations Team Award", which demonstrates the market's recognition of Fosun International's corporate management and operations, information disclosure, transparency, and communication with stakeholders, and affirms Fosun's long-term investment value. Despite the headwinds of anti-globalization in 2022, Fosun is still a firm practitioner of globalization. In 2022, COMIRNATY® COVID-19 mRNA vaccine continued to provide an anti-epidemic barrier for Hong Kong SAR, Macao SAR and the Taiwan region; Club Med opened new resorts; Lanvin Group was successfully listed on the New York Stock Exchange. In the face of uncertainties, Fosun remained committed to technology and innovation in order to weather market cycles. HANQUYOU, independently developed by Henlius, was successfully launched in Australia after entering the European Union market; the registration application in the Chinese Mainland for the new indication of Yi Kai Da, China's first CAR-T cell therapy was officially accepted. Fosun attaches great importance to its development. No matter how policies and markets change, Fosun will always devote its best efforts. Fosun is actively making strategic adjustments in the face of the constant changes in the macro environment and revealed the future development direction of Fosun: Fosun will reinforce its positioning as "a global innovation-driven consumer group", focus on its core businesses strategically around the consumption needs of global families, and strengthen the two core growth engines of globalization and innovation. The market is optimistic about Fosun's strategies of accelerating its strategic transformation and focusing on household consumption sectors. A number of investment banks, including Morgan Stanley, Citi, Goldman Sachs and Nomura, have published reports and assigned Fosun International an "Overweight" or "Buy" rating. Market analyst believes that as the "one-off" negative impact of the external environment clears, Fosun's continuous focus on the family-oriented consumer sector will usher in an important period of opportunity for business rebound in 2023. Since the beginning of the year, Fosun's main businesses centering on household consumption, such as Health, Happiness, and Wealth, have shown signs of strong recovery and Fosun's forward-looking efforts in the anti-epidemic field have gradually borne fruit. The two flagships of Fosun's Happiness segment, Fosun Tourism Group and Yuyuan, and other businesses have shown strong signs of recovery. According to market sources, when the domestic tourism industry suffered a huge setback in 2022, Fosun Tourism Group still stood firm to build global presence and opened seven new Club Med resorts throughout the year. Club Med's global bookings in the first half of 2023 have greatly exceeded the same period in 2019 before the pandemic. During the 2023 New Year holiday period, Atlantis Sanya, FOLIDAY Town Lijiang and other businesses in China all performed better than their respective pre-pandemic levels, and many Club Med resorts in China recorded close to 100% occupancy. During the 2023 New Year holiday period, the 2023 Yuyuan Garden Lantern Festival in the Grand Yuyuan attracted a large number of tourists. It is expected that the Spring Festival will further unleash consumption vitality. Fosun's solid fundamentals and recovery potential have been widely recognized by financial institutions and investors On 16 January 2023, Shanghai Fosun High Technology (Group) Co., Ltd. ("Fosun High Technology"), the domestic operating entity of Fosun International, received a RMB12 billion syndicated loan from eight domestic banks. This is the largest private enterprise loan led by five major state-owned banks in cooperation with policy banks and joint-stock banks since the Central Economic Work Conference explicitly proposed in December 2022 to encourage and support the development of the private economy and private enterprises. Moreover, Fosun High Technology successfully completed bookbuilding for the RMB1 billion super & short-term commercial paper on 13 January 2023. According to a report published by S&P Global Ratings, Fosun International's total debt at the holding company level could drop by 15%-25% in 2023 as the company continues to dispose assets and pay down matured bonds, thereby further improving its liquidity. According to incomplete statistics, Fosun's return of capital from its asset reduction in 2022 has reached tens of billions of yuan. Morgan Stanley also issued a report commenting that Fosun's syndicated loan can further improve its liquidity, significantly helping lift market confidence in Fosun's stability. Looking ahead, the reopening of China will help boost fundamentals, especially in businesses such as tourism, retail, and investment. 2022 marked the 30th anniversary of Fosun's establishment. Standing at the new starting point of 30 years of establishment, Fosun will continue to strengthen its core businesses, deepen innovation and globalization. Fosun will continue to join hands with customers, partners, investors and all parties in the society to forge ahead and continue to uphold its original aspiration of "Contribution to Society", so as to actively promote the sustainable development of ESG to fulfil Fosun's mission of "Creating Happier Lives for Families Worldwide". About The Asset Corporate Awards Organized by The Asset, a renowned Asian financial magazine, The Asset Corporate Awards is one of the world's leading and longest-running awards. The judging committee, which composes of professional investors and analysts, assesses the overall performance including financial performance, corporate governance, social and environmental responsibility, information disclosure and corporate communication of listed companies in the Asia-Pacific region through online questionnaire submissions made by the participating companies, then follow by obtaining feedback from the investor community and analysts through interview, in order to select and award the winning companies based on the overall score. It has a strong influence in Asia and the international capital markets.
#fruit
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
